NCT02649764 2023-10-04Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeM.D. Anderson Cancer CenterPhase 1 Completed15 enrolled